ACK1: Small molecule ACK1 Inhibitors for the Treatment of Castrate Resistant Prostate Cancer
FOR MORE INFORMATION ON THIS TECHNOLOGY, PLEASE CONTACT OUR OFFICE
Contact
Haskell Adler PhD MBA CLP
Senior Licensing Manager
Haskell.Adler@Moffitt.org
(813) 745-6596